XML 122 R99.htm IDEA: XBRL DOCUMENT v3.20.1
Goodwill - Impairment testing (Details)
€ in Millions
12 Months Ended
Dec. 31, 2019
EUR (€)
item
Dec. 31, 2018
EUR (€)
Jan. 26, 2018
Jul. 25, 2017
Sep. 30, 2014
Impairment Testing          
Length of cash flow projections used in assumptions and calculations of impairment 5 years 5 years      
Term of the government bonds 30 years        
Stock market capitalization | € € 18,831 € 13,978      
Kiro Grifols S.L (formerly Kiro Robotics S.L)          
Impairment Testing          
Percentage of voting equity interests acquired       40.00% 50.00%
Goetech, LLC. ("MedKeeper")          
Impairment Testing          
Percentage of voting equity interests acquired     51.00%    
Grifols Diagnostics Solutions, Inc.          
Impairment Testing          
Percentage of voting equity interests acquired 45.00%        
Bioscience          
Impairment Testing          
Perpetual growth rate 2.00% 2.00%      
Pre-tax discount rate 8.80% 8.90%      
Diagnostic          
Impairment Testing          
Perpetual growth rate   2.00%      
Pre-tax discount rate   9.40%      
EBITDA multiple | item 14.5        
Hospital          
Impairment Testing          
Perpetual growth rate 1.50% 1.50%      
Pre-tax discount rate 10.80% 13.10%